AffirmHealth Blog

Talking to Your Patients About Opioid Abuse: A Clinician’s Guide

Posted by Mario Ramirez, MD on Jan 16, 2019 9:08:02 AM

0 Comments

At AffirmHealth, our work focuses around working with clinicians to ensure that they are prescribing opioids in a reliable and compliant manner that gives administrators insight into what is happening across their organizations.  From the clinician’s viewpoint, my job is to help ensure that the clinical information and the decision support we implement works in a way that actually improves care delivery to the patient—after all, if our work isn’t actually making care better, then we’re doing a disservice to the patient.  While our blog has covered a wide range of critical issues around these topics, one thing we’ve never actually discussed is how clinicians should approach the topic of opioid abuse with their patients, strategies for successful risk screening, and what to do if one of your patients develops an opioid use disorder.

READ MORE

2018 DEA Drug Threat Assessment: Key Findings

Posted by John Cole on Jan 9, 2019 9:04:33 AM

0 Comments

In November of 2018, the DEA released the results of the 2018 National Drug Threat Assessment. The 164 page report highlighted the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. The DEA’s acting administrator, Uttam Dhillon, said the assessment “underscores the magnitude of the nation’s opioid crisis and highlights the necessity of using all the tools at our disposal to fight this epidemic.”1

READ MORE

Opioids: A Global perspective. Treating Pain and Battling Addiction.

Posted by Jody Lutz on Jan 2, 2019 2:34:09 PM

0 Comments

The Opioid Epidemic in America is a topic covered extensively, each and every day in the news. AffirmHealth covers this topically frequently as well, most recently in our, "Where are We Now?" article.

READ MORE

Teens and Opioid Abuse

Posted by Jody Lutz on Dec 18, 2018 3:34:22 PM

0 Comments

 

Historically, research has shown that nearly 1 in 4 high school  seniors  in the United States have been exposed to prescription opioids through either medical or non-medical use. On November 12, 2018 a JAMA abstract reported: Between 1997 and 2012, the rate of hospitalization due to opioid poisonings nearly doubled in US children and adolescents. Opioid use early in life is associated with a higher likelihood of opioid misuse in the future.
READ MORE

The Opioid Epidemic at the End of 2018: Are We Making Progress?

Posted by Mario Ramirez, MD on Dec 11, 2018 9:31:00 AM

0 Comments

For those of us involved in the opioid epidemic as caregivers, patient advocates, and researchers, there was an interesting moment earlier this year when a series of news stories noted some optimism in the fight against overdose deaths. 

In mid-October, Health and Human Services Secretary Alex Azar commented on preliminary data from the U.S. Centers for Disease Control and Prevention that suggested “that the U.S. may be ‘beginning to turn the tide’ on the opioid crisis.[1]”  “The seemingly relentless trend of rising overdose deaths seems to be finally bending in the right direction…We are so far from the end of the epidemic, but we are perhaps at the end of the beginning.[2]” 

READ MORE

The Future of Managing Pain: Novel Treatments & Reformulations

Posted by Jody Lutz on Nov 28, 2018 2:26:19 PM

0 Comments

As the opioid misuse and overdose epidemic impacts communities across America and has sweeping global implications, practitioners are looking to the future of pain management and the novel treatment options that may be on the horizon.

READ MORE
dsuvia, FDA, Raeford Brown, Opioid Therapy, Opioid Epidemic

The Controversial Approval of Dsuvia by the Food and Drug Administration

Posted by Mario Ramirez, MD on Nov 21, 2018 8:23:13 AM

0 Comments

Earlier this month on November 2nd, the U.S. Food and Drug Administration approved Dsuvia, a new sublingual version of an older drug, sufentanil, that has been in use since 1984. 

READ MORE

MIPS and Improvement Activity Data

Posted by Jody Lutz on Nov 13, 2018 3:28:24 PM

0 Comments

Last week on the AffirmHealth Blog we discussed MIPS and PDMP Usage and promised a follow up on additional Improvement Activities. So this week we look at an Improvement Activities Data overview as well as a handful of activities potentially pertinent to providers prescribing opioids or other controlled substances.

Let’s start at the beginning…

READ MORE

 

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.

PROTECT YOUR PATIENTS.
PROTECT YOUR PRACTICE.

Drive responsible, compliant opioid prescribing across your organization.

SCHEDULE A CALL

Comments

Categories

see all

Popular Posts